atropine Archives - Insight Presented by Prime Creative Media Thu, 11 Aug 2022 06:12:57 +0000 en-US hourly 1 https://www.insightnews.com.au/wp-content/uploads/2024/02/cropped-Insight-favicon-32x32.png atropine Archives - Insight 32 32 Atropine for myopia control: science and practice https://www.insightnews.com.au/atropine-for-myopia-control-science-and-practice/ Mon, 04 Apr 2022 21:37:48 +0000 https://www.insightnews.com.au/?p=26539
The optimum atropine concentration for myopia has been the focus of studies that have offered several twists.

At the completion of this CPD activity, optometrists will have developed their knowledge of atropine as a treatment for myopia management. Including:  Understand the clinical rationaleRead More

The post Atropine for myopia control: science and practice appeared first on Insight.

]]>
The optimum atropine concentration for myopia has been the focus of studies that have offered several twists.
At the completion of this CPD activity, optometrists will have developed their knowledge of atropine as a treatment for myopia management. Including: 
 Understand the clinical rationale
Read More

The post Atropine for myopia control: science and practice appeared first on Insight.

]]> Complaints over compounded atropine eye drops in NSW https://www.insightnews.com.au/complaints-over-compounded-atropine-eye-drops-in-nsw/ Tue, 14 Sep 2021 21:47:05 +0000 https://www.insightnews.com.au/?p=22619
The FDA also cited quality issues related to product sterility.

The post Complaints over compounded atropine eye drops in NSW appeared first on Insight.

]]>
The FDA also cited quality issues related to product sterility.
The Pharmacy Council of New South Wales has reported a rise in complaints over compounded atropine eye drops, with one patient lodging their grievance with Ahpra after becoming aware the formulation was
Read More

The post Complaints over compounded atropine eye drops in NSW appeared first on Insight.

]]> Atropine dose comparison shows a clear winner for myopia control https://www.insightnews.com.au/atropine-dose-comparison-shows-a-clear-winner-for-myopia-control/ Thu, 19 Nov 2020 21:33:55 +0000 http://www.insightnews.com.au/?p=17863
The study assessed three different atropine strengths for myopia control.

The post Atropine dose comparison shows a clear winner for myopia control appeared first on Insight.

]]>
The study assessed three different atropine strengths for myopia control.
A concentration of 0.05% atropine slowed the rate of myopia progression in pre-teen children compared with two other concentrations of the drug, according to findings published in Ophthalmology. Researchers
Read More

The post Atropine dose comparison shows a clear winner for myopia control appeared first on Insight.

]]> Twin licensing deals bolster Bausch + Lomb’s myopia portfolio https://www.insightnews.com.au/twin-licensing-deals-bolster-bausch-lombs-myopia-portfolio/ Tue, 27 Oct 2020 22:16:45 +0000 http://www.insightnews.com.au/?p=17426 multifocal contact lenses atropine myopia
The efficacy of combined use of multifocal contact lenses and and 0.01% atropine remains unclear.

The post Twin licensing deals bolster Bausch + Lomb’s myopia portfolio appeared first on Insight.

]]> multifocal contact lenses atropine myopia
The efficacy of combined use of multifocal contact lenses and and 0.01% atropine remains unclear.
Bausch + Lomb has acquired an exclusive license for a novel myopia control contact lens developed by a Sydney ophthalmic research institute, just days after signing another deal to commercialise an investigational
Read More

The post Twin licensing deals bolster Bausch + Lomb’s myopia portfolio appeared first on Insight.

]]>